<p>In this descriptive analysis, any patients from Simbi sector who consulted Simbi HC from October 1st, 2021, to November 26th, 2021 and presented with at least three symptoms including fever, abdominal pain, diarrhea, vomiting, nausea, headache, or body weakness were documented in the line list. Using patient interviews and clinical records, demographic, clinical, laboratory and environmental assessment characteristics were recorded for each patient in Epi Info. Blood and stool samples of newly presenting patients who met the inclusion criteria were collected and sent to the National Reference Laboratory for culture and antibiotic sensitivity test (AST).</p>